Document Detail

A pharmacokinetic simulation tool for inhaled corticosteroids.
MedLine Citation:
PMID:  23139018     Owner:  NLM     Status:  MEDLINE    
The pharmacokinetic (PK) behavior of inhaled drugs is more complicated than that of other forms of administration. In particular, the effects of certain physiological (mucociliary clearance and differences in membrane properties in central and peripheral (C/P) areas of the lung), formulation (as it relates to drug deposition and particle dissolution rate), and patient-related factors (lung function; effects on C/P deposition ratio) affect the systemic PKs of inhaled drugs. The objectives of this project were (1) to describe a compartmental model that adequately describes the fate of inhaled corticosteroids (ICS) after administration while incorporating variability between and within subjects and (2) based upon the model, to provide a freely available tool for simulation of PK trials after ICS administration. This compartment model allows for mucociliary removal of undissolved particles from the lung, distinguishes between central and peripheral regions of the lung, and models drug entering the systemic circulation via the lung and the gastrointestinal tract. The PK simulation tool is provided as an extension package to the statistical software R ('ICSpkTS'). It allows simulation of PK trials for hypothetical ICS and of four commercially available ICS (budesonide, flunisolide, fluticasone propionate, and triamcinolone acetonide) in a parallel study design. Simulated PK data and parameters agreed well with literature data for all four ICS. The ICSpkTS package is especially suitable to explore the effect of changes in model parameters on PK behavior and can be easily adjusted for other inhaled drugs.
Benjamin Weber; Guenther Hochhaus
Related Documents :
23800338 - Relatively high prevalence of drug resistance among antiretroviral-naïve patients from...
21198438 - Statin drugs, metabolic pathways, and asthma: a therapeutic opportunity needing further...
22934218 - Priapism in antipsychotic drug use: a rare but important side effect.
22943408 - Management of difficult multidrug-resistant tuberculosis and extensively drug-resistant...
22039878 - Lights and shadows on monoamine oxidase inhibition in neuroprotective pharmacological t...
18407918 - The nitrate reductase assay for the rapid detection of isoniazid and rifampicin resista...
Publication Detail:
Type:  Journal Article     Date:  2012-11-10
Journal Detail:
Title:  The AAPS journal     Volume:  15     ISSN:  1550-7416     ISO Abbreviation:  AAPS J     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-01-03     Completed Date:  2013-08-02     Revised Date:  2013-11-14    
Medline Journal Info:
Nlm Unique ID:  101223209     Medline TA:  AAPS J     Country:  United States    
Other Details:
Languages:  eng     Pagination:  159-71     Citation Subset:  IM    
Department of Pharmaceutics, College of Pharmacy, Center of Pharmacometrics and Systems Pharmacology, University of Florida, 1600 SW Archer Road, P3-33, Gainesville, FL 32610, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Administration, Inhalation
Adrenal Cortex Hormones / administration & dosage,  pharmacokinetics*
Clinical Trials as Topic
Models, Biological
Reg. No./Substance:
0/Adrenal Cortex Hormones

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Case studies for practical food effect assessments across BCS/BDDCS class compounds using in silico,...
Next Document:  The utility of modeling and simulation approaches to evaluate immunogenicity effect on the therapeut...